The store will not work correctly when cookies are disabled.
N-(5-fluoropyridin-2-yl)-6-(5-fluoropyridin-3-yloxy)-3-methyl-[1,2,4]triazolo[4,3-a]pyridine-8-carboxamide
ID: ALA4094617
PubChem CID: 118104069
Max Phase: Preclinical
Molecular Formula: C18H12F2N6O2
Molecular Weight: 382.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nnc2c(C(=O)Nc3ccc(F)cn3)cc(Oc3cncc(F)c3)cn12
Standard InChI: InChI=1S/C18H12F2N6O2/c1-10-24-25-17-15(18(27)23-16-3-2-11(19)7-22-16)5-14(9-26(10)17)28-13-4-12(20)6-21-8-13/h2-9H,1H3,(H,22,23,27)
Standard InChI Key: WBWHBHWEZVQLRK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
21.4602 -12.9430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8767 -13.7620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8739 -12.9394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1653 -12.5341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1671 -14.1715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4593 -13.7655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8545 -14.3132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1885 -15.0577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9997 -14.9700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1628 -11.7169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8693 -11.3062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5761 -11.7151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2821 -11.3050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2801 -10.4870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5662 -10.0807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8632 -10.4930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5609 -9.2635 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.5851 -14.1695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5864 -14.9867 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2921 -13.7598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0005 -14.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9972 -14.9829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7047 -15.3903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4127 -14.9806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4088 -14.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7007 -13.7554 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1216 -15.3871 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.0547 -14.1456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0
5 2 1 0
2 3 2 0
3 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
4 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
2 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
7 28 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 382.33 | Molecular Weight (Monoisotopic): 382.0990 | AlogP: 3.15 | #Rotatable Bonds: 4 |
Polar Surface Area: 94.30 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.41 | CX Basic pKa: 2.51 | CX LogP: 0.96 | CX LogD: 0.96 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.58 | Np Likeness Score: -1.76 |
References
1. Felts AS, Rodriguez AL, Morrison RD, Bollinger KA, Venable DF, Blobaum AL, Byers FW, Thompson Gray A, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA.. (2017) Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5., 27 (21): [PMID:28958625] [10.1016/j.bmcl.2017.09.042] |